Furuta M, Horinouchi H, Yokota I, Yamaguchi T, et al. Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small-cell lung cancer (NEJ056). Cancer Sci 2024 Sep 15. doi: 10.1111/cas.16340.
PMID: 39278260